Laura Valerio

9PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersWomen's studies (incl. girls' studies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 27, 2026
Familial Status Modulates the Stability of Excellent Response in Non-Medullary Thyroid Carcinoma: Implications for Tailored Surveillance.

|Apr 08, 2025
Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study).

Giulia Puliani, Marta Bianchini, Carlotta Giani

|Mar 10, 2025
Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer.

Laura Valerio, Antonio Matrone

|Jun 27, 2024
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer.

Laura Valerio, Silvia Cantara, Elisa Mattii

|Sep 28, 2023
Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer.

Laura Valerio, Cristina Dalmiglio, Fabio Maino

|Apr 19, 2023
Enlargement of a metastatic lymph node from differentiated thyroid cancer after COVID-19 vaccination.

Laura Valerio, Alessandro Prete, Ferruccio Santini

Pageof 2

Frequent Collaborators

4 joint publications

Rossella Elisei

3 joint publications

Alfonso Sagnella

2 joint publications

Silvia Cantara

2 joint publications

Andrea Trimarchi